News & Updates

Show Multimedia Only

Labetalol, nifedipine equally effective for chronic hypertension in pregnancy

23 Feb 2023 by

Treatment with either labetalol or nifedipine is similarly effective in reducing adverse maternal outcomes among women with mild chronic hypertension (CHTN) in pregnancy, according to a study presented at SMFM 2023.

Labetalol, nifedipine equally effective for chronic hypertension in pregnancy

23 Feb 2023

Cannabis use among expectant mums compromises pregnancy

22 Feb 2023 by

Pregnant women may do well to avoid cannabis, with cannabis use in early pregnancy leading to adverse pregnancy outcomes, as reported in a study presented at Society for Maternal-Fetal Medicine (SMFM) 43rd Annual Pregnancy Meeting.

Cannabis use among expectant mums compromises pregnancy

22 Feb 2023

Which ART delivers better HIV viral suppression in pregnant women?

22 Feb 2023 by

Pregnant women living with HIV are more likely to achieve viral suppression when treated with dual-nucleoside reverse transcriptase inhibitors (NRTI) in combination with integrase (INSTI) inhibitors compared to protease (PI) inhibitors at delivery, suggests a recent study presented at the 43rd Annual Pregnancy Meeting of the Society for Maternal Fetal Medicine (SMFM 2023).

Which ART delivers better HIV viral suppression in pregnant women?

22 Feb 2023

Can oxytocin be discontinued during active labour?

22 Feb 2023 by

Discontinuing oxytocin during the active stage of labour appears safe, according to the STOPOXY trial presented at SMFM 2023.

Can oxytocin be discontinued during active labour?

22 Feb 2023

Hypertensive disorders of pregnancy tied to fatty, salty diet

21 Feb 2023 by

Women who adhere to a diet rich in sodium, dairy, and saturated fats are at increased risk of hypertensive disorders of pregnancy (HDP), according to a study presented at the 43rd Annual Pregnancy Meeting of the Society for Maternal Fetal Medicine (SMFM 2023).

Hypertensive disorders of pregnancy tied to fatty, salty diet

21 Feb 2023

Original-New-Drug-Application-Approvals-by-US-FDA--01-15-February-2023

20 Feb 2023

New drug applications approved by US FDA as of 01-15 February 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--01-15-February-2023

20 Feb 2023

Endometrioma ups risk of failing antibiotic treatment for pelvic inflammatory disease

18 Feb 2023

Among women with pelvic inflammatory disease, the presence of endometrioma is associated with a lower likelihood of responding to antibiotic treatment and a higher risk of surgical intervention, according to a study.

Endometrioma ups risk of failing antibiotic treatment for pelvic inflammatory disease

18 Feb 2023

Hydrochlorothiazide–lisinopril combo bests nifedipine for BP control in postpartum hypertension

17 Feb 2023

In women with postpartum hypertension, treatment with combined hydrochlorothiazide (HCTZ)/lisinopril yields greater blood pressure (BP)-lowering benefit than nifedipine monotherapy, according to the results of a pilot study.

Hydrochlorothiazide–lisinopril combo bests nifedipine for BP control in postpartum hypertension

17 Feb 2023

Vacuum-induced device controls postpartum haemorrhage in just 5 mins

17 Feb 2023 by

Uncontrolled postpartum haemorrhage (PPH) is a life-threatening complication of childbirth that is temporarily managed with uterine balloon tamponade. At SMFM 2023, researchers from the US presented findings for a new device that could control PPH safely and effectively in just 5 minutes.

Vacuum-induced device controls postpartum haemorrhage in just 5 mins

17 Feb 2023

Single-dose azithromycin during labour prevents maternal death, sepsis

15 Feb 2023 by

Treatment with a single oral dose of azithromycin, given to women in labour who were planning a vaginal birth, significantly reduced the risk of maternal death or sepsis, according to the A-PLUS* trial presented at SMFM 2023.

Single-dose azithromycin during labour prevents maternal death, sepsis

15 Feb 2023

News & Updates

Showing Obstetrics & Gynaecology articles

Showing

Specialty:

Labetalol, nifedipine equally effective for chronic hypertension in pregnancy

Labetalol, nifedipine equally effective for chronic hypertension in pregnancy

Cannabis use among expectant mums compromises pregnancy

Cannabis use among expectant mums compromises pregnancy

Which ART delivers better HIV viral suppression in pregnant women?

Which ART delivers better HIV viral suppression in pregnant women?

Can oxytocin be discontinued during active labour?

Can oxytocin be discontinued during active labour?

Hypertensive disorders of pregnancy tied to fatty, salty diet

Hypertensive disorders of pregnancy tied to fatty, salty diet

Original-New-Drug-Application-Approvals-by-US-FDA--01-15-February-2023

Original-New-Drug-Application-Approvals-by-US-FDA--01-15-February-2023

Endometrioma ups risk of failing antibiotic treatment for pelvic inflammatory disease

Endometrioma ups risk of failing antibiotic treatment for pelvic inflammatory disease

Hydrochlorothiazide–lisinopril combo bests nifedipine for BP control in postpartum hypertension

Hydrochlorothiazide–lisinopril combo bests nifedipine for BP control in postpartum hypertension

Vacuum-induced device controls postpartum haemorrhage in just 5 mins

Vacuum-induced device controls postpartum haemorrhage in just 5 mins

Single-dose azithromycin during labour prevents maternal death, sepsis

Single-dose azithromycin during labour prevents maternal death, sepsis